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In humans, a considerable number of the autopsy samples of cognitively normal
individuals aged between 57 and 102 years have revealed the presence of amyloid
plaques, one of the typical signs of AD, indicating that many of us use mechanisms that
defend ourselves from the toxic consequences of Aß. The human APP NL/F (hAPP NL/F)
knockin mouse appears as the ideal mouse model to identify these mechanisms, since
they have high Aß42 levels at an early age and moderate signs of disease when old.
Here we show that in these mice, the brain levels of the hemoprotein Neuroglobin (Ngb)
increase with age, in parallel with the increase in Aß42. In vitro, in wild type neurons,
exogenous Aß increases the expression of Ngb and Ngb over-expression prevents
Aß toxicity. In vivo, in old hAPP NL/F mice, Ngb knockdown leads to dendritic tree
simplification, an early sign of Alzheimer’s disease. These results could indicate that
Alzheimer’s symptoms may start developing at the time when defense mechanisms start
wearing out. In agreement, analysis of plasma Ngb levels in aged individuals revealed
decreased levels in those whose cognitive abilities worsened during a 5-year longitudinal
follow-up period.
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INTRODUCTION
Numerous studies in different experimental settings demonstrate the direct association between
an excess of oligomeric forms of Aβ peptide and the appearance of some of the pathological signs
characteristics of Alzheimer’s disease (AD) (Walsh et al., 2002; Li et al., 2009; Dinamarca et al.,
2012). However, 30 to 50% of cognitively normal individuals aged between 57 and 102 years show
AD pathological hallmarks after autopsy (Haroutunian et al., 1999; Aizenstein et al., 2008). This
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suggests that environmental and biological factors may offer
compensation against AD pathological hallmarks. The proof
in vivo that it is possible to counteract the toxicity exerted by
a high Aβ burden by biological factors is found in a particular
group of early-onset AD patients carrying the presenilin 1
(PSEN1) E280A mutation that increase Aβ production and
induce amyloid accumulation in the brain. While PSEN1-E280A
carriers develop dementia at the median age of 49 years, carrying
a mutation on the AD risk modifier ApoE3 (R136S) delayed
dementia significantly, until the 7th decade (Arboleda-Velasquez
et al., 2019), demonstrating that Aβ accumulation is not enough
to develop AD. By impairing the binding to heparan sulfate
proteoglycans (HSPGs), the ApoE3 (R136S) mutant may avoid
tau pathology spread (Arboleda-Velasquez et al., 2019) and
Aβ – induced microglia activation in the brain (Bussini et al.,
2005). Even more, there is a time-window during which the
presence of oligomeric forms of this peptide does not produce
significant alterations, implying the action of mechanisms that
counteract the toxic effects of these peptides. As a matter of
fact, data accumulated over the last years have revealed that
neuropathological and biochemical changes occur decades before
neuro-degeneration and clinical manifestation of AD symptoms
(Troncoso et al., 1996, 1998; Price and Morris, 1999; Bennett
et al., 2006). The study of autosomal dominant forms of the
disease have revealed that Aβ deposition in the brain of pre-
symptomatic individuals is observed up to 20 years before the
onset of the symptoms (Rodriguez-Vieitez et al., 2016). Also,
in sporadic forms of AD, increased Aβ levels are detected in
plasma-derived neuronal exosomes up to 10 years before the
manifestation of the first symptoms (Fiandaca et al., 2015). All
these data imply the existence of robust resilience mechanisms,
such as the recently identified PLA2 G4E (Perez-Gonzalez et al.,
2020), counteracting the detrimental effect of different toxicity
factors, including excessive production of the more damaging
forms of Aβ peptide. The identification of these mechanisms is
a fundamental process if we want to prevent or cure this disease.
There have been numerous proposals for mechanisms that
protect neurons against the toxicity of Aβ aggregation, effective in
in vitro and in vivo models (Yan and Wang, 2008). However, these
works highlight potential mechanisms that could protect but do
not help us to know what physiological mechanisms are operating
to protect the brain of subjects exposed during a long period of
time to elevated levels of the toxic forms of Aβ. A good model to
look for physiological constitutive protective mechanisms is the
humanized (Aβ region) APP knockin mouse bearing the Swedish
and Iberian mutations (hAPP NL/F), since this mouse presents
high levels of Aβ42 from very early ages with mild symptoms of
pathology at late ages (Saito et al., 2014; Masuda et al., 2016).
MATERIALS AND METHODS
Antibodies
The following antibodies were used for the Western Blot
analysis: rabbit anti-Akt (Cell Signaling, dilution 1:500), rabbit
anti-pSer473 Akt (Cell Signaling, dilution 1:500), rabbit anti-
Bcl-2 (Bioworld, dilution 1:500), rabbit anti-Ubiquitin (Santa
Cruz, dilution 1:500), mouse anti-Tau 5 (Thermo, dilution
1:500), mouse anti-GAPDH (Abcam, dilution 1:10,000), rabbit
anti-GSK3β (Invitrogen, dilution 1:500), rabbit anti-Hsp-70
(Enzo, dilution 1:1000), rabbit anti-JNK (Cell Signaling, dilution
1:500), rabbit anti-LAMP 2A (Invitrogen, dilution 1:500),
rabbit anti-LC3 (Sigma, dilution 1:1000), rabbit anti-Ngb
(Genetex, dilution 1:500), rabbit anti-P62 (Cell signaling,
dilution 1:500), rabbit anti-pThr180/Tyr182 p38 MAPK (Cell
Signaling, dilution 1:1000), rabbit anti-pThr183/Tyr185 JNK
(Cell Signaling, dilution 1:500), mouse anti-pTyr216 GSK3β
(Millipore, dilution 1:500), rabbit anti-p38 MAPK (Abcam,
dilution 1:1000) and rabbit anti-Ser396/Ser404 Tau (PHF1)
(provided by Prof. Jesus Ávila, CBMSO, Spain, dilution 1:500).
For the immunofluorescence analysis the following antibodies
were used: mouse anti-DDK (FLAG) (Origene, dilution 1:1000),
rabbit anti-CD45 (Abcam, dilution 1:1000), rabbit anti-GFAP
(Millipore, dilution 1:1000), rabbit anti-Iba-1 (Wako, dilution
1:1000), rabbit anti-NeuN (Abcam, dilution 1:1000), rabbit
anti-Ngb (Sigma-Aldrich, dilution 1:200) and rabbit anti-tGFP
(Thermo, dilution 1:2500).
hAPP NL/F Mice
hAPP NL/F mice were made on C57BL/6J background as detailed
in Saito et al. (2014). All the animals were kept in the Centro
de Biología Molecular Severo Ochoa’s (CBMSO) animal facility.
The mice and manipulations presented in this work count with
the approval of the Dirección General de Medio Ambiente
de la Comunidad Autónoma de Madrid (Ref. PROEX 066/15)
and the CBMSO’s Ethical Committee. All the experiments
were performed in accordance with European Union guidelines
(2010/63/UE) regarding the use of laboratory animals. Only
males were used for this study, the ages of which are specified
in each figure legend. All the experimental procedures with
laboratory animals were carried out in accordance with the
European directive transposed into the Spanish legal system in
RD 53/2013, of 1 February, which establishes the basic rules
applicable for the protection of animals used in experimentation
and other scientific purposes.
Genotyping
For the genetic identification of homozygous hAPP NL/F mice,
genomic DNA was extracted from the tail by digestion of
the tissue with proteinase K (Merck) at 10 mg/ml in lysis
buffer (50 mM Tris–HCl pH 8, 100 mM NaCl, 100 mM
EDTA, SDS 1%) at 60◦C for 2 h and then the DNA was
purified to carry out the polymerase chain reaction (PCR).
The fragments corresponding to the WT allele (700 bp) or
the mutated allele (400 bp) were amplified using the following
oligonucleotides: WT forward ATCTCGGAAGTGAAGATG,
WT reverse TGTAGATGAGAACTTAAC; NL-F forward AT
CTCGGAAGTGAATCTA, NL-F reverse CGTATAATGTATG
CTATACGAAG. A PCR program with the following protocol
(Ta, duration, number of cycles) was used: (i) 94◦C, 3 min, 1
cycle; (ii) 94◦C, 30 s, 57◦C, 30 s, 72◦C, 30 s, 30 cycles; (iii) 72◦C,
1 min, 1 cycle; the PCR product was labeled with RedSafeTM
and separated by agarose gel electrophoresis to visualize the
amplified fragments.
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Quantification of Aβ in the Cerebral
Cortex of APP NL/F Mice
Aβ was extracted from the cerebral cortex of 3, 9, and
24 months APP NL-F mice. The mice were deeply sedated
with an intraperitoneal (ip) injection of sodium pentobarbital
(500 mg/Kg) and perfused with 0.9% sodium chloride. After
perfusion, the brain was removed and the cortices were dissected
and homogenized in 500 µl of homogenization buffer (0.5 M
Tris HCl, 0.15 M NaCl Tween-20 0.05% 2 mM EDTA, pH
7.6) with protease inhibitors (cOmpleteTM, Sigma-Aldrich). The
sample was then ultracentrifuged at 200,000 g for 20 min at 4◦C
to separate the soluble and insoluble fraction. The supernatant
(soluble fraction) was reserved for further analysis, and the pellet
was resuspended in guanidinium chloride HCl (GndCl) 6 M,
sonicated and stirred for 1 h at 23◦C, to solubilize the insoluble
Aβ. Then, it was ultracentrifuged at 200,000 g for 20 min at 4◦C
and the supernatant was collected (insoluble fraction).
The levels of Aβ38, Aβ40, and Aβ42 were measured by MSD
(Meso Scale Discovery) multiplex immunoassay (Meso Scale
Diagnostics, LLC) following the instructions of the manufacturer.
Briefly, after blocking the wells with 150 µl of blocking buffer
(0.1% casein in PBS) for 2 h at RT, they were washed 5 times
with 200 µl of wash buffer (0.05% Tween-20 in PBS). Next,
test samples or standard peptides (human Aβ38, Aβ40, and
Aβ42 peptides) were diluted and prepared with the detection
antibody (4G8) conjugated to an electrochemiluminescence label
(SULFO-TAGTM) and loaded 50 µl in each well of the MSD
multiplex plate. The plates were incubated at 4◦C overnight and
the next day they were washed 2 times with 150 µl of commercial
development buffer (MSD T). Electrochemiluminescence was
evaluated with the MSD Sector Imager 6000 apparatus.
Determination of mRNA Levels in the
Cerebral Cortex of APP NL/F Mice by
Quantitative Reverse Transcription PCR
(qRT-PCR)
RNA was extracted using Direct-zolTM RNA minipreps (Zymo
Research ref.: R2052). RNA was quantified at 260 nm absorbance
using a NanoDrop ND-100 (Thermo Fisher Scientific). The
amount of mRNA present in mouse cortex or neurons in culture
was assessed by qPCR. To this end, complementary DNA was
synthesized from mRNA by reverse transcriptase PCR (RT-PCR)
using a commercial kit (RevertAid H Minus First Strand cDNA
Synthesis Kit, Thermo Fisher Scientific) under a 3-step PCR
program (Ta, duration): (i) 25◦C, 5 min; (ii) 42◦C, 60 min;
(iii) 70◦C, 5 min. Next, 5 ng of synthesized cDNA were used to
perform the qPCR using a commercial kit (GoTaq R© qPCR Master
Mix, Promega). The oligonucleotides needed to amplify the
region of interest were designed in regions of exons flanking long
introns (intron-spanning), to avoid amplification of genomic
DNA. The oligonucleotides used at a 0.5 µM final concentration
for each gene are described in the following table.
The ABI PRISM 7900HT SDS (Applied Biosystems)
equipment was used to perform the qPCR, in which a 3-
step PCR protocol was programmed (Ta, duration, number of











cycles): (i) 95◦C, 2 min, 1 cycle; (ii) 95◦C, 3 s, 60◦C, 30 s, 40
cycles; (iii) 95◦C, 15 s, 60◦C, 15 s and recovery with an increase
of 7%, up to 95◦C, 1 cycle. Ct (cycle threshold) was quantified
as a relative measure of the concentration of PCR product. Fold
changes were calculated with the 11Ct method (Livak and
Schmittgen, 2001). The housekeeping gene PGK1 was used as an
endogenous control. In addition, the fusion curves were analyzed
to check the specificity of the reaction. All the experiments were
performed in triplicate and qPCR data was analyzed with the
SDS program (Applied Biosystems).
Analysis of Protein Expression by
Western Blot
Cortex of WT or APP NL/F mice were dissected for biochemical
studies and homogenized in disruption buffer (Thermo Fisher
Scientific) with protease inhibitors (cOmpleteTM, Sigma-
Aldrich), phosphatases (Sigma-Aldrich). For primary cultures,
after the corresponding treatment they were washed with
cold PBS and lysed in RIPA buffer (20 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP−40, 1%
sodium deoxycholate, 0.1% SDS) with phosphatase inhibitors
(Sigma-Aldrich) and proteases (cOmpleteTM, Sigma-Aldrich).
Proteins were prepared in Laemmli buffer (Tris–HCl 25 mM
ph 6.8, sodium dodecyl sulfate (SDS) 1%, glycerol 3.5%, 2-
mercaptoethanol 0.4% and bromophenol blue 0.04%) and
separated by electrophoresis in polyacrylamide gels in the
presence of SDS at constant voltage. Subsequently, they were
transferred onto nitrocellulose membranes and after blocking
with blocking solution [5% bovine serum albumin (BSA) in 0.1%
Tween-20 in PBS (T-PBS)], membranes were incubated with
the corresponding primary antibody diluted in blocking buffer
overnight at 4◦C. After washing the membranes with T-PBS, they
were incubated with the relevant secondary antibodies coupled
to horseradish peroxidase and diluted 1/5000 for 1 hr at RT. The
proteins recognized by the antibodies were detected with luminol
(PierceTM ECL Western Blotting Substrate, Thermo Fisher
Scientific) and chemiluminescence was measured using a CCD
camera (Amersham Imager 680). A given protein of interest
was quantified by using the FIJI image-processing software to
measure the average pixel intensity of the band corresponding to
the protein in the digital image and was normalized with respect
to the values obtained for the control protein GAPDH.
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Determination of Protein Concentration
The concentration of proteins present in the homogenates was
determined by means of the BCA assay (PierceTM BCA Protein
Assay kit, Thermo Fisher Scientific), following the indications of
the commercial kit.
LDH Toxicity Assay
The toxicity of the in vitro treatments was assessed by the release
of the enzyme lactate dehydrogenase (LDH) to the extracellular
medium. At the end of the corresponding treatment, 500 µl of the
culture medium was collected and used to perform a colorimetric
assay with a commercial kit (Pierce LDH Cytotoxicity Assay Kit,
Thermo Fisher Scientific). The enzymatic reaction in the presence
of LDH produces formazan, whose absorbance peak is 490 nm.
The percentage of cytotoxicity of each treatment was calculated
considering as 100% those cells treated with lysis buffer.
Culture of Primary Cortical Neurons
The cerebral cortices from mouse embryos (E18) were dissected
in HBSS medium (Hanks Buffer Salt Solution Ca2 + and
Mg2 + free, Thermo Fisher Scientific) and digested with trypsin
(Thermo Fisher Scientific) at 0.012% for 15 min at 37◦C. The
tissue was then disintegrated and resuspended in plating medium
[Minimum Essential Media (Thermo Fisher Scientific) with 20%
glucose and 10% horse serum (Invitrogen)]. The cells were seeded
in the same medium on culture plates with coverslips pre-coated
overnight at 37◦C with 0.5 mg/ml poly-D-lysine (Sigma-Aldrich)
at a density of 9,000 cells/cm2 for immunofluorescence studies
or culture plates previously treated overnight at 37◦C with
0.1 mg/ml poly-L-lysine (Sigma at a density of 10,000 cells/cm2
for biochemical analysis. After 3 h plating medium was replaced
by Neurobasal medium (Thermo Fisher Scientific) supplemented
with B27 (Thermo Fisher Scientific) and Glutamax (Thermo
Fisher Scientific). Neurons were maintained at 37◦C and 5% CO2
for the necessary time. Half of the medium was replaced by fresh
medium once a week and Glutamax was removed on the 7th day
in vitro (DIV 7).
Treatment of Primary Cortical Neurons
Treatment of Primary Neurons With Synthetic Aβ42
Synthetic human Aβ42 (Anaspec) was resuspended in dimethyl
sulfoxide (DMSO) at a concentration of 5 mM, and sonicated to
ensure a homogeneous solution of monomers. In order to obtain
oligomers, the peptide was diluted to 100 µM in DMEM and
after vortexing, it was incubated overnight at 4◦C. The state of
aggregation of the peptide was verified by transmission electron
microscopy. Due to the fact that B27 supplement contains
antioxidants in its formulation, and antioxidants are known to
inhibit Aβ-mediated toxicity (Ono et al., 2006; Manczak et al.,
2010; Giordano et al., 2014; Rajasekhar et al., 2020), we replaced
the media by Minimal Essential Medium (MEM) containing
antioxidants-free N2 supplement, which has been previously
used to study Aβ toxicity (Bateman et al., 2007; Uchida et al.,
2011; Ungureanu et al., 2016). On DIV 8, the B27-supplemented
medium was progressively replaced (1/4 of the media each
day for 3 days, the 4th day being totally replaced) with MEM
media supplemented with N2 (Gibco; Life Technologies Co.) and
without GlutaMAX, and subsequently treated with oligomeric
Aβ to study dendritic arborization (100 nM), mitochondrial
respiration (10 µM) or Ngb expression (5 µM), at 8 DIV, 10 DIV
or 14 DIV, respectively.
Treatment of Primary Neurons With H2O2
Prior to the treatment, the medium was progressively replaced
(see above paragraph) with medium supplemented with N2 to
eliminate antioxidants present in B27 supplement that could
mask the action of H2O2. The H2O2 solutions were prepared
fresh, making the corresponding dilutions in water and in such a
way that the volume of treatment did not exceed 10% of the total
volume of the well. Neurons were treated at 10 DIV with 10 µM
H2O2 to assess mitochondrial respiration, or at 8 DIV with 1 and
10 µM to study Ngb expression.
Determination of ROS Levels by DHR on
Histological Sections of the Brain of
hAPP NL/F Mice
The presence of ROS in the cortex of the mice was evaluated
using dihydrorhodamine (DHR) (Thermo Fisher Scientific), a
pigment that upon oxidation in the presence of ROS emits
green fluorescence. After extracting the brain and making coronal
sections of 350 µm thickness, the slices were kept for 1 h at 32◦C
with artificial cerebrospinal fluid (aCSF) bubbled with a mixture
of 5% CO2 and 95% O2. Subsequently, they were incubated for
10 min with 10 µM DHR in aCSF at RT at darkness. After 2
washes of 15 min with PBS, the slices were fixed for 2 h with 4%
PFA. Non-specific unions were blocked for 30 min with blocking
buffer (2% BSA and 0.5% Triton X-100 in PBS). The cell nuclei
were labeled with DAPI 1: 5000 in PBS for 15 min. The slices were
mounted with Mowiol on a slide for observation under a confocal
microscope (DAPI: λ = 405 nm, DHR: λ = 488 nm). The signal
intensity in the green channel was evaluated after extracting the
signal from the lipofuscin granules, which are autofluorescent at
all wavelengths.
Analysis of Dendritic Complexity
In order to study the complexity of the dendritic tree,
dendrites were immunostained with anti-tGFP for neurons
of animals injected with virus or anti-MAP2 for primary
neurons infected in culture. In both cases, confocal images
of isolated neurons at several planes (z stack) were taken
with an overlap of 40%. The 8-bit images were processed
with the Simple Neurite Tracer program of the FIJI software.
Subsequently, the morphological complexity was studied by
means of the Sholl analysis, in which the number of neurites
crossing each of the imaginary circles of increasing radius
(10 µm) that are drawn around the soma is determined.
A graph is obtained in which the number of intersections
from the cellular soma to the periphery is represented. The
number of primary dendrites (projecting directly from the cell
soma) and secondary or higher dendrites (projecting from a
dendrite), as well as the number of bifurcation points were
also quantified.
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Generation of Lentiviral Vectors
All the necessary procedures to produce lentiviruses were carried
out in a culture room with a P2 biosecurity level. Second-
generation lentiviral particles were created in order to introduce
and integrate the mentioned plasmids in the neuronal nucleus
in a stable and long-lasting manner. For this purpose, HEK
293-T cell line were transfected with a packaging plasmid
(pCMV delta R 8.2, Addgene), a shell plasmid VSV-G (pMD2.G,
Addgene) coding for vesicular stomatitis virus glycoproteins,
and the following plasmids of interest: for the Ngb silencing
experiment, a silencing plasmid (sh-Ngb) (Origene, TL503454a)
or a scrambled (Scr) (Origene, TR30021) were used, while
for the Ngb overexpression experiment, a plasmid containing
the sequence for Ngb expression (Origene, NM_021257) was
used. The transfection was carried out when cells reached 80%
confluence by mixing the 3 plasmids prepared in OptiMEM
(Thermo Fisher Scientific) and using polyethyleneimine (PEI,
Sigma) in a PEI: DNA 1: 1 ratio. After 12 h, the medium was
replaced by DMEM with 2% FBS and the cells were maintained
at 37◦C for an additional 48 h. After this time, the medium was
collected and centrifuged at 900 g for 15 min at 4◦C to remove
cell debris and filtered with a 0.22 nm pore filter (Millipore).
Subsequently the supernatant was ultracentrifuged at 60,000 g
for 2 h at 4◦C. The pellet corresponding to the lentivirus was
resuspended in sterile PBS and frozen in single-use aliquots that
were maintained at−80◦C.
The concentration of lentiviruses, expressed in Transducing
Units (TU)/ml, was estimated by flow cytometry. For this, HEK
293T cells were infected with increasing concentrations of virus
and the percentage of infected cells (positive for tGFP) after 48 h
was obtained. The 3 lentivirus preparations showed high titers,
between 108 and 109 TU/ml. Neuronal cultures were infected at
6 DIV with a MOI (multiplicity of infection) of 5. To do this,
on the day of infection, the amount of lentivirus needed was
resuspended in 200 µl of conditioned medium and added to
the culture of neurons dropwise. The next day, the medium was
completely replaced by B27-supplemented Neurobasal medium.
Immunofluorescence Analysis
Immunofluorescence of Neurons in Culture
Primary neurons on coverslips were washed 3 times with PBS and
fixed with 4% PFA for 15 min at RT. Next cells were blocked and
permeabilized with blocking solution (2% BSA and 0.1% Triton
X-100 in PBS) for 1 h at RT and subsequently incubated overnight
at 4◦C with the corresponding primary antibody. After 3 washes
with PBS, coverslips were incubated with secondary antibodies
conjugated with fluorophores (1: 5000 in PBS) for 1 h at RT.
Subsequently they were washed with PBS and the cell nuclei were
labeled with DAPI (1: 5000 in PBS). Slices were mounted with
Mowiol for observation under a confocal microscope.
Immunofluorescence of Brain Tissue
The left hemisphere of the brain of the mice, or the entire brain
in the case of animals injected with lentivirus, was fixed by
immersion in 4% PFA and 0.2 M sucrose in PBS overnight at
4◦C. They were then cryoprotected with 30% sucrose in PBS, after
which 40 µm thick sagittal sections were made with a vibratome
(Leica VT1200 S). Sections were collected and maintained at
−20◦C in a cryoprotective solution (30% ethylene glycol and 26%
glycerol in 0.1 M phosphate buffer (PB) pH 7).
Brain sections were permeabilized and blocked with blocking
solution (2% BSA and 0.5% Triton X-100 in PBS) for 1 h at
RT and subsequently incubated with the corresponding primary
antibody overnight at 4◦C. The next day and after performing
3 washes with PBS, the sections were incubated with secondary
antibodies conjugated with fluorophores (dilution 1: 500 in
blocking solution) for 1 h at RT. Then, they were washed with
PBS and the nuclei were labeled with DAPI (1: 5000 in PBS)
for 15 min. Sections were mounted with Mowiol on slides for
analysis with a confocal microscope. Negative controls were
included for each immunofluorescence reaction in order to check
the specificity of the primary antibody. For this, sections were
incubated only with the secondary antibody.
Detection of Amyloid Plaques
The deposition of β-amyloid was detected by the fluorescent
pigment thioflavin S (Th-S) (Merck), whose peak of excitation
and maximum emission are 430 and 550 nm, respectively. The
fixed brain sections were incubated for 15 min with 0.1% Th-S in
50% diluted ethanol, after which they were washed 2 times with
50% ethanol and subsequently with distilled water. The images
were acquired with an inverted fluorescence microscope Axiovert
200 (Zeiss) coupled to a sCMOS camera (Excitation 461–488 nm,
Emission 499–530 nm).
Study of Mitochondrial Activity
Mitochondrial activity was assessed by 3- (4,5-dimethylthiazol-
2-yl) -2,5-diphenyltetrazolium bromide (MTT) (Sigma). For this
experiment, 10,000 neurons per well were plated in a 96-well plate
and at 6 DIV they were infected with a control lentivirus or a
lentivirus expressing Ngb. After the corresponding treatments at
10 DIV, the medium was replaced by 100 µl of 0.5% MTT diluted
in N2-supplemented medium. The cells were kept at 37◦C for 4 h
to allow formation of formazan crystals, which were subsequently
dissolved by adding 50 µl of DMSO. After 15 min at 37◦C, the
absorbance at 560 nm was read.
LTP and LTD Experiments
Field excitatory postsynaptic potentials (fEPSPs) were recorded
in the stratum radiatum of CA1 on hippocampal slices. The
recording chamber was perfused with artificial CSF (aCSF)
(120 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4, 11 mM glucose)
with 0.1 mM picrotoxin and in bubbling with 5% CO2 and
95% O2. Bipolar stimulation electrodes were placed between the
collaterals of Schaffer and the glass of the recording electrodes
(1–2 M, covered with aCSF) at a distance of 200 µm, in the
direction of projection of the fibers. The depth of the electrode
was adjusted to achieve a maximum synaptic response size in
the given CA1 region. Records were made at 0.066 Hz with
stimuli of 50 µs in duration, and a stable baseline of 20–
30 min was acquired before experimental manipulation. An
input-output curve was generated and a stimulus was established
that would produce a maximum response of 50 or 30% of the
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maximum response for long-term depression (LTD) and long-
term potentiation (LTP), respectively. The LTD was induced by
low frequency stimulation of Schaffer collateral fibers (900 pulses
at 1 Hz). A theta-burst stimulation protocol (TBS) was used to
induce LTP: 4 series (at 20 s intervals) of 10 bursts (at 5 Hz) of 4
pulses (at 100 Hz).
Water Morris Test
Before beginning the experiment, for 2 days the mice were
introduced into the pool with a visible platform and their capacity
to swim correctly was checked. In the learning phase, the mice
were introduced into the pool facing the wall from 4 different
positions each day, determined randomly. Mice were allowed to
swim until they found the platform, and the time taken by each
mouse was recorded. Four sessions per day were performed, with
1 min of rest between them, until the mice learned to find the
platform (4 days).
On the 5th day, the test was performed to assess the memory
of each subject. The platform was removed from the pool and the
mouse was allowed to swim for 90 s. In this case, the time that the
mouse spent in the quadrant where the platform was located (Q1)
and in the opposite quadrant (Q3) was evaluated. From the 6th
day, the inverse learning test was performed to evaluate learning
dependent on the prefrontal cortex and working memory. For
this, a hidden platform was reintroduced, but this time in Q3,
so that the mice had to learn the new position of the platform.
Four sessions per day were carried out for 4 days and the
time it took for the subject to learn the new position of the
platform was evaluated.
Fear Conditioning Test
The hippocampal and amygdala-dependent memory was
assessed using the fear conditioning test. In this test the mice
receive an unconditioned stimulus (tone of 3 KHz of frequency
and 80 dB of intensity) and a conditioned aversive stimulus
(electrical discharges in the legs of 0.8 mA of intensity). The
experiment takes place in a box with electrified metal floor
and covered in red methacrylate to prevent the animal from
seeing the outside, but allowing the experimenter to assess the
movements of the mouse throughout the experiment.
On day 1, a mouse was introduced into the box and allowed to
habituate to the environment for 3 min. After this time, 3 sessions
of electric shocks of 2 s duration each one were applied and each
of them preceded by a tone of 20 s. During this session, mice learn
to associate the context and tone with the electric shocks.
On day 2, the same mouse was reintroduced in the same
compartment for 5 min. The subjects capable of associating the
context with the electric discharges show a behavior of total
immobilization, whose duration was assessed as an index of
memory associated with fear.
During day 3, the memory associated with the amygdala is
evaluated, for which the context is completely changed (light
conditions, smell, etc.) and the same tone is emitted as the first
day. After allowing the mouse to get used to the new context for
2 min, the tone was emitted for 5 min. The immobilization time
in this case is interpreted as the ability to associate the tone with
the electric shocks, and measures a type of memory that is related
to the amygdala.
The last day it was found that all the mice had the same
sensitivity in the legs, for which the minimum intensity at
which the subjects show signs of pain (vocalizations and
jumps) was assessed.
Stereotactic Injection
To study the effect of Ngb silencing in vivo, a lentivirus
expressing an shRNA against Ngb (Ngb shLenti) was injected
into the somatosensory cortex of 16-month-old APP NL/F
mice, using the following coordinates: anteroposterior
(Bregma): + 0.11; mediolateral: ± 0.15; dorsoventral: −0.18. We
injected the shRNA lentivirus in one hemisphere and the control
lentivirus expressing and scrambled shRNA (scr shLenti) in the
contralateral hemisphere of the same mouse.
The mice were kept under deep sedation by inhalation of
anesthesia (isoflurane) throughout the procedure. The loss of
body temperature was controlled with the aid of a thermal
blanket and the ocular dryness was prevented by ocular
moisturizing cream.
The mouse head was fixed to the stereotactic apparatus by
means of buccal and auricular fixations, and two holes were
made in the skull with the help of a microdrill and a 1 mm
diameter drill. Using a Hamilton syringe (Series 700 87930,
Hamilton) with a 30G gauge needle (7762-03, Hamilton), 1 µl of
the corresponding lentivirus was injected into each hemisphere
at a rate of 0.2 µl/min.
At the end of the surgery, the incision in the scalp was sutured
with surgical thread and local anesthetic cream was applied.
The mouse was reanimated on an electric blanket and 200 µl
of PBS ip was injected to prevent dehydration. Also, they were
monitored for a week, with analgesic (Dalsy) in the drinking
water. All procedures were carried out in an animal room with
a P2 biosecurity level.
After 2 months, the mice were perfused and their brain cut
into sections, as described above. With the help of an Axiovert
200 (Zeiss) fluorescence microscope, the sections were selected
with infected cells for further study and analysis.
Determination of NGB Levels in Plasma
of Patients
Plasma samples were obtained from the Biobank of the
Alzheimer Research Centre of the Queen Sofia Foundation.
Plasma of donors was drawn in the first visit (V1) and the
fifth visit, 5 years later (V5), and who did not show a cognitive
decline between V5 and V1 (Stable group; Mean age: 75 years,
n = 14), or with signs of mild cognitive impairment (MCI)
at V5 versus V1 (Converters group; Mean age: 74.85 years;
n = 7). Human blood samples were extracted, processed and
stored at CIEN Foundation (Madrid, Spain) following the Vienna
Protocol (Institute of Neurology, University of Vienna, May 2001.
Modified proposal blood collection WHO 080501) essentially as
previously described (Olazarán et al., 2015; Kenny et al., 2019).
Briefly, after approval of the Local Ethics Committee and signing
informed consent, blood samples were drawn in the presence
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of citrate and centrifuged at 2,280 × g for 5 min followed by
separation of the plasma fraction and additional centrifugation
for 10 min at 16,000×g to obtain the platelet-free plasma sample,
which was stored at −80◦C until use. The whole process was
performed within 1 h of procurement.
After thawing, plasma was centrifuged at 1000 g at 4◦C
for 15 min and the supernatant was used to determine NGB
levels with a commercial ELISA kit for the detection of human
neuroglobin (Cloud-Clone Corp.) following the instructions
of the manufacturers. The optimal dilution of plasmas to
determine NGB levels was assessed in a pilot test. Briefly,
plasma samples were diluted in 1X PBS and a standard curve
was set up with 7 points: 500 pg/ml, 250 pg/ml, 125 pg/ml,
62,5 pg/ml 31.2 pg/ml, 15.6 pg/ml, 7.8 pg/ml. 100 µL of
sample or standard were loaded onto the corresponding well
of the ELISA plate and were incubated for 1 h at 37◦C. After
the incubation, 100 µL of Detection Reagent A provided by
the manufacturer and the plate was incubated for 1 h at
37◦C. After 3 times washes with Washing Buffer, 100 µL of
Detection Reagent B was added per well and the plate was
incubated for 30 min at 37◦C (both buffers were provided
by the manufacturer). The plate was washed 5 times with
washing buffer, and 90 µL of Substrate Solution was added
per well. After 20 min, the reaction was stopped with 50 µL
of Stop Solution and absorbance was read at 450 nm in a
spectrophotometer.
Statistical Analysis
Statistical analyses of the data were performed with the
SPSS (IBM) program. To analyze the effect of factors of
two levels, the normality of the sampling distribution was
checked by means of the Shapiro-Wilk test and the means
were compared by means of the two-way Student t-test. In
the case of factors of more than two levels, the one-way
ANOVA followed by the Tukey post hoc test was used to
compare the means between the different groups. To study
the effect of 2 factors on a studied variable, a two-way
ANOVA was performed to study the effect of each of the
factors, as well as the possible interaction between them,
and a Tukey post hoc analysis was followed to compare the
means of the different groups. Values of P less than 0.05 were
considered significant.
Ethics Approval and Consent to
Participate
All the experimental procedures with laboratory animals
were carried out in accordance with the European directive
transposed into the Spanish legal system in RD 53/2013, of
1 February, which establishes the basic rules applicable for
the protection of animals used in experimentation and other
scientific purposes.
The procedures for obtaining of plasma samples were
approved by the Ethics Committee of Research and Animal
Welfare of the Carlos III Health Institute. Donors signed an
informed consent form and data was protected according the
Spanish Law on Protection of Personal Data (15/1999).
RESULTS
Absence of Alzheimer Signs in Old hAPP
NL/F Mice
Analysis of the concentration of different human Aβ species
(Aβ38, Aβ40, and Aβ42) in the cerebral cortex of hAPP NL/F
mice of various ages revealed a characteristic age-associated
increase in both the soluble (Figure 1A) and the insoluble
(aggregated peptide) (Figure 1B) fractions, already evident in
3-month-old mice. When we compared the increment of the
soluble and insoluble forms of the different Aβ peptides over age,
the highest increment corresponded to Aβ42, the most toxic form
of the species analyzed (El-Agnaf et al., 2000; Yan and Wang,
2006), giving rise to the increase with age of the pathologically
relevant Aβ42/Aβ40 ratio (Figure 1C).
Despite the high levels of Aβ and the increase in the
Aβ42/40 ratio, the old hAPP NL/F mice, we could not
detect major pathological changes in these mice. We were
not able to detect, even in 24-month-old mice, microgliosis
(Supplementary Figures S1A-C), pro-inflammatory
(Supplementary Figures S1D,E) or anti-inflammatory
(Supplementary Figures S1F,G) reaction. We also did
not detect significant changes in proteasomal function
(Supplementary Figure S2A), nor in protein stress response
(Supplementary Figure S2B), which are found elevated in
AD patients (Lukiw, 2004). The autophagosomal pathway
was also not altered, reflected by similar levels of LC3
and P62 (Supplementary Figures S2C,D), nor was it the
chaperone-mediated autophagy, as shown by the unaltered
levels of LAMP2A along time (Supplementary Figure S2E).
Also, no differences were observed in terms of activation
of pro-apoptotic (Supplementary Figure S2F) or canonical
pro-survival Akt activity (Supplementary Figures S2G,H)
pathways. We did, however, detect an increase in the number
of reactive astrocytes compared to age-matched WT mice
(Supplementary Figure S3A) and an increase in the levels
of tau phosphorylation at the pathogenic epitope Pair Helical
Filament-1 (PHF1) (pSer396/404) (Supplementary Figure S3B).
Given that excess of Aβ is associated with defects in synaptic
transmission (Walsh et al., 2002; Li et al., 2009; Dinamarca
et al., 2012), we carried out experiments to evaluate the hAPP
NL/F mice at the electrophysiological and behavioral levels. For
this, we performed both LTP (Long Term Potentiation) and
LTD (Long Term Depression) recordings in hippocampal slices
from old hAPP NLF and also Morris Water Maze and the Fear
Conditioning tests. A strong LTP response was induced upon
stimulation both in hippocampal slices from WT and hAPP
NL/F mice (Figure 2A). Regarding the LTD response, it was
initially induced but did not remain stable a long time, regardless
of the genotype (Figure 2B). Similarly, we did not observe
differences in memory and learning performance between WT
and hAPP NL/F mice. As measured by the Morris Water Maze,
both showed similar learning curves during training (Figure 2C),
although strikingly, did not spend more time exploring the
target quadrant (Q1) during the probe day, when the platform is
removed (Figure 2D). When the platform position was changed,
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FIGURE 1 | The levels of Aβ species increase in the cerebral cortex of APP NL/F during aging. (A) Quantification using the MSD-Vplex assay of the Aβ species
present in the soluble extracts from the cerebral cortex of 3, 9, and 24 months-old APP NL/F mice. Aβ levels at 9 and 24 months were compared to 3 months (n = 4
mice per age and genotype; *p < 0.05, ***p < 0.001 vs. 3 months; ###p < 0.001 vs. Aβ 40). (B) Quantification using the MSD-Vplex assay of the Aβ species
present in the insoluble extracts from the cerebral cortex of 3, 9, and 24 months-old APP NL/F mice. Aβ levels at 9 and 24 months were compared to 3 months
(n = 4 mice per age and genotype; *p < 0.05, **p < 0.01, ***p < 0.001 vs. 3 months; ##p < 0.01, ###p < 0.001 vs. Aβ 40). (C) Changes of the pathologically
relevant Aβ42/Aβ40 ratio over aging were plotted for insoluble and soluble Aβ by using the raw data shown in panels (A,B). Aβ42/Aβ40 ratio at 9 and 24 months was
compared to 3 months (n = 4 mice per age and genotype; **p < 0.01). Statistical significance was analyzed by one-way ANOVA followed by Tukey post hoc analysis.
both WT and hAPP NL/F mice were able to learn the new
position, the latter reaching the platform even faster than WT
mice during the last trial (Figure 2E). Confirming these results,
the Fear Conditioning test showed no differences in contextual
(hippocampus-associated) memory or emotional (amygdala-
dependent) memory (Figure 2F). Although these results may
seem surprising given the high levels of toxic forms of amyloid
peptide, similar results were observed in a previous work on the
same hAPP NL-F mice (Masuda et al., 2016).
Aβ42 Oligomers Trigger Neuroglobin
Expression via Oxidative Stress
As shown in the above series of results, even in the presence
of high levels of toxic forms of Aβ over a long period of time,
we could not find broad pathology in the cortex of this mouse
model of AD. Hence, we envisioned that these mice put to
work very robust defense mechanisms against the toxic effects
of Aβ, perhaps similar to those operating in individuals without
cognitive deficits but with a high amyloid load. To identify
these mechanisms in these mice, we analyzed the expression
levels of selected toxic (Supplementary Figures S4A,B) and
survival (Supplementary Figures S4A,C) genes whose levels
of expression were found altered in the brains of individuals
affected by AD. Of the 9 genes studied, only Neuroglobin
(Ngb) mRNA levels increased with aging in the hAPP NL/F
mice but not in WT mice (Figure 3A). The increase in Ngb
was also observed at the protein level only in the hAPP NL/F
mice, whereas in the WT mice remained stable a long time
(Figures 3B,C).
Ngb is an oxygen transporter and NO scavenger hemoprotein
expressed in the brain and retina that protects cells from
death after ischemia and reperfusion after damage (Burmester
et al., 2000; Raychaudhuri et al., 2010; Tiso et al., 2011).
Furthermore, Ngb increases in conditions of oxidative stress
in different models (Li et al., 2008a, 2010; Watanabe et al.,
2012; Amri et al., 2017). Given that Aβ also produces oxidative
stress (Smith et al., 2007; Streltsov et al., 2008; Butterfield
and Boyd-Kimball, 2019), and that our mice produce high
amounts of Aβ (see Figures 1A–C), we studied next if the
Aβ is able to increase the expression of Ngb. To test this
possibility, we exposed mouse cortical neurons from wild type
mice maintained in culture for 10 days to 5 µM Aβ42 oligomers
for 24 h. The phosphorylation status of P38 MAPK, which is
enhanced upon Aβ exposure via a mechanism involving oxidative
stress, was increased after treating neurons with Aβ oligomers
(Figure 3D) and this effect was reduced if neurons were pre-
treated with 2 mM of the anti-oxidant N-acetylcysteine (NAC),
thus proving the efficacy of the protocol used. Importantly, Aβ42
oligomers increased Ngb protein levels and this was reversed
by NAC (Figure 3E), pointing to ROS as the mediator of
the effect. Consistent with this assumption, treating primary
neurons with a non-toxic concentration of H2O2 (Figure 3F)
increased Ngb expression (Figure 3G). We also observed high
levels of ROS in the cortex of hAPP NL/F mice, which
would also indicate that the age-associated increase in Ngb
in these mice is strongly associated with increased oxidative
stress, likely linked to the presence of elevated levels of Aβ
(Figures 3H–J).
Ngb Protects Neurons Against
Aβ-Induced Mitochondrial Stress
Aβ oligomers produce neuronal toxicity through, among
many other mechanisms, affecting mitochondrial function
(Lustbader et al., 2004; Manczak et al., 2010). In this direction,
it has been proposed that Ngb protects against cell death
by decreasing nitric oxide (NO) formation and preventing
cytochrome C-induced caspase 9 activation (Raychaudhuri
et al., 2010; Tiso et al., 2011). To determine whether or
not increased levels of Ngb protect neurons against Aβ-
toxicity, primary cortical neurons were transduced with empty
lentiviral particles (LV-cnt) as a negative control or lentiviral
particles containing the DNA sequence for Ngb (LV-NGB)
(Figures 4A,B). 4 days post-transduction, 10 µM H2O2
or Aβ oligomers, at concentrations known to be toxic
(Figures 4C,D), were added to the media and the levels of
reduced MTT by mitochondria evaluated. While Aβ oligomers
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FIGURE 2 | Synaptic plasticity, learning and memory are not affected in old APP NL/F mice. (A,B) LTP induction by TBS (A) and LTD by LFS (B) on hippocampal
slices of WT and hAPP NL/F mice. The number n of slices used of N animals of each genotype is defined. The graphs show the mean ± SEM, two-way Student t,
(ns: not significant, vs. WT). (C) Graphic representation of the latency time to the platform in APP NL/F and WT mice during the learning phase of the Morris water
maze. Statistical significance was analyzed by T test of repeated samples. (D) Analysis of the percentage of swimming time in the target quadrant (Q1) and the
opposite quadrant (Q3) on the day of the test (n = 5 WT mice and 7 NL/F mice). The graphs show the mean ± SEM. Statistical significance was analyzed by
two-way T test. (ns: not significant vs. WT). (E) Reversal learning curve, in which the submerged platform has changed position (n = 5 WT mice and 7 NL/F mice).
The graphs show the mean ± SEM. Statistical significance was analyzed by two-way T test. (ns: not significant) (*p < 0.05, vs. WT). (F) Graphic representation of
the freezing time percentage of hAPP NL/F and WT mice during the exposure to the context related to the aversive stimulus (left) or to the tone (right) (n = 5 WT mice
and 8 NL/F mice). The mean ± SEM is represented. Statistical significance was analyzed by t test of two ways (ns: not significant, vs. WT).
and H2O2 treatment decreased the reduction of MTT in
control-infected neurons (Figures 4E,F), those infected with
LV-NGB had levels of reduced MTT similar to neurons that
had not been treated either with Aβ or hydrogen peroxide
(Figures 4E,F), thus confirming the anti-stress, protective role
of this protein.
Ngb Protects Against Aβ
Oligomers-Induced Dendritic Shrinkage
Aβ is widely known to be itself an important source of ROS
(reviewed in Butterfield and Boyd-Kimball, 2019). In turn,
accumulated ROS can have deleterious consequences on the
function of brain cells, including the perturbation of the neurons’
dendritic architecture (Landino et al., 2004; Fukui et al., 2011).
Mechanistically, alterations in the stability of microtubule are
considered responsible for the architectural defects observed
in a highly oxidized environment (Landino et al., 2004; Fukui
et al., 2011). Thus, Aβ, perhaps via oxidative stress (but not
only), would affect microtubule organization and dynamics and
consequently neuronal architecture. In support of this possibility,
recent works have shown that changes in microtubules and
dendritic simplification are among the earliest manifestation of
Aβ toxicity (Wu et al., 2010; Deng et al., 2019). More importantly,
dendritic tree simplification is a typical feature of early AD,
both in vivo in animal models of the disease and in the human
brain (Golovyashkina et al., 2015). Therefore, in view of our
results showing that the over-expression of Ngb reduces the
oxidative stress induced by Aβ peptide, we investigated if the
higher levels of Ngb in the brains of our hAPP NL/F mice
could have prevented the appearance of architectural defects
produced by this peptide, and consequently the initiation of
the AD phenotype. To test this possibility, we first analyzed
the effect of ectopic Ngb on Aβ-mediated dendritic architecture
alterations in vitro analyzed by the number of dendritic crossings
of circles centers at the soma and with increasing radius
(Figures 4G,H). Consistent with published work, 100 nM Aβ
oligomers reduced the complexity of the dendritic tree of
primary cortical neurons in culture (Figures 4G–I). Dendritic
bifurcations (Figure 4J) and second- or higher-order dendrites
(Figure 4K) were less abundant in primary cortical neurons
treated with Aβ oligomers compared to non-treated neurons.
These results are in agreement with published findings that Aβ
triggers the pruning of dendrites progressively from the synapses
inward, affecting spines and higher-order branches without
impacting the number of primary dendrites. This, however, did
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FIGURE 3 | Ngb expression is enhanced in the cerebral cortex of old APP NL/F mice. (A) Ngb mRNA levels quantified in the cerebral cortex by qRT-PCR increase
over aging only in hAPP NL/F mice. (n = 4 mice per genotype; *p < 0.05 vs. 3 months, #p < 0.05 vs. WT). (B,C) Ngb protein levels determined in the cerebral cortex
by western blot increase in old hAPP NL/F (B) mice but not in WT (C) (of note: antibody specificity was tested by shRNA knockdown and by over-expression:
Figure 1 for Reviewer 1). Plots show quantification of western blot experiments (n = 4 mice per age; *p < 0.05, ns: not significant, vs. 3 months). (D) Electron
microscopy image of Aβ42 (scale bar = 100 nm). In order to obtain Aβ42 oligomers, synthetic human Aβ42 monomers were diluted in DMEM and incubated
overnight at 4◦C. Oligomers are pointed out by arrowheads. (E) Western blot showing the activation in 14 DIV primary neurons of p38 (phospho Tyr 180/Thr 182)
after 24 h treatment with 5 µM Aβ42 oligomers [prepared like in Panel (D)] and its decrease with pre-treatment with 2 mM NAC (n = 6; bars represent the
mean ± SEM; *p < 0.05, #p < 0.05, ns:not significant). (F) 5 µM Aβ42 oligomers trigger the expression of Ngb in primary cortical neurons and it is reverted by 2 mM
NAC. A plot with the quantification of Ngb for the different conditions is shown (n = 6; *p < 0.05, #p < 0.05, ns: not significant). (G) Plot showing the toxicity of H2O2
treatment in cortical neurons determined by LDH release (n = 4; *p < 0.05 vs. vehicle (Cnt), ns: not significant). (H) 10 µM H2O2 treatment induces the expression of
Ngb protein in cortical neurons determined by western blot. The plot shows the quantification of 4 independent western blot experiments (*p < 0.05, ns: not
significant). (I) Analysis of the ROS labeling with DHR in cortical slices of hAPP NL/F mice, and WT mice (n = 12 slices from 3 mice of old WT and hAPP NL/F and 5
slices from 2 mice of young hAPP NL/F; *p < 0.05, ###p < 0.001). (J) Representative confocal images of hAPP NL/F mice of 3 and 24 months, and WT mice of
24 months, labeled against ROS with DHR. Scale bar: 50 µm. Statistical significance was analyzed by two-way (panel A) or one-way [panels (B,C) and (E–I)]
ANOVA, without interaction, followed by Tukey post hoc analysis. Bars represent the mean ± SEM. (3 m, 12 m, 24 m means 3 months, 12 months, and 24 months,
respectively).
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FIGURE 4 | Overexpression of Ngb rescues H2O2- and Aβ-induced mitochondrial dysfunction and loss of dendritic complexity. (A) Representative confocal images
of neurons infected with control lentivirus (LV-Cnt) or lentivirus overexpressing Ngb (LV-NGB) both expressing tGFP, and immunostained for Ngb and tGFP. Scale bar:
20 µm. (B) Graph showing the intensity for Ngb calculated from confocal images like the one shown in Panel (A) (n = 10 neurons from 3 independent cultures;
*p < 0.05). (C) Curve showing mitochondrial activity measured by MTT assay after exposing primary cortical neurons to different concentrations of H2O2 [n = 3;
*p < 0.05, **p < 0.01 vs. vehicle (Cnt)]. (D) Curve showing mitochondrial activity measured by MTT assay after exposing primary cortical neurons to different
concentrations of oligomeric Aβ42 [n = 3; *p < 0.05, **p < 0.01 vs. vehicle (Cnt)]. (E,F) Decrease in mitochondrial activity of cortical neurons determined by
reduction of MTT and induced by 10 µM H2O2 (E) or 10 µM Aβ42 oligomers (F) is rescued by overexpressing Ngb (LV-NGB) (n = 8; *p < 0.05, **p < 0.01,
***p < 0.001). (G) Representative traces of the dendritic arborization of 14 DIV neurons in culture infected with a control lentivirus (LV-cnt) or a lentivirus
overexpressing Ngb (LV-NGB), and treated or not with 100 nM Aβ42 oligomers for 24 h (Scale bar: 20 µm). (H) Sholl analysis to determine the dendritic complexity
of neurons treated or not with 100 nM Aβ42 oligomers and infected with a control lentivirus (LV-cnt) or a lentivirus to overexpress Ngb (LV-NGB) (n = 15 neurons from
3 independent cultures of each group; *p < 0.05). (I) Graph representing the area under the curve calculated from Panel (H) (*p < 0.05). (J–L) Dendritic bifurcations
(J) and higher-order dendritic branches (K) are less abundant in primary neurons treated with 100 nM Aβ42 oligomers compared to non-treated cortical neurons,
while no statistical differences are observed for primary branches (L). These effects are reverted by overexpression of Ngb (LV-NGB) (*p < 0.05, **p < 0.01). The
graphs show the mean SEM. Statistical significance was analyzed by one-way ANOVA followed by Tukey’s post hoc analysis, except for panel B, which was
analyzed by Statistical significance was analyzed by two-tailed t test.
not happen for primary dendritic branches and in neurons
overexpressing Ngb (Figures 4J–L).
To determine if this role of protecting the integrity of the
dendritic tree occurs in vivo, we injected a lentivirus expressing
an shRNA against Ngb (LV-shRNA-Ngb) or a scrambled
shRNA (LV-shRNA-cnt) (Supplementary Figures S5A,B) in
the cortex of old hAPP NL/F mice (Figure 5). Mice were
sacrificed 2 months post-injection and their brains were
analyzed by immunofluorescence. Interestingly, downregulation
of Ngb levels caused a reduction of dendritic complexity in
the neurons of the injected area (Figure 5A) as revealed
by Sholl analysis, not observed in LV-shRNA-cnt injected
animals (Figures 5B–D). Similar to the results obtained
in vitro after Aβ treatment, downregulation of Ngb resulted
in fewer dendritic bifurcations (Figure 5E) and fewer second-
or higher-order dendritic branches dendrites (Figure 5F),
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FIGURE 5 | Ngb downregulation reduces the dendritic complexity of cortical pyramidal neurons in old APP NL/F mice. (A) Confocal image representative of the area
infected with a lentivirus expressing an shRNA against Ngb and turboGFP (tGFP) (sh-Ngb). Nuclei are stained with DAPI and cortical layers are indicated.
(B) Representative traces of the dendritic arborization of cortical neurons of the layer III infected with a control lentivirus (sh-cnt) or sh-Ngb to downregulate Ngb.
(Scale bar: 20 µm). (C) Sholl analysis to determine the dendritic complexity of neurons infected with a control (sh-cnt; n = 17 sh-cnt neurons in total analyzed from 4
mice) or silencing (sh-Ngb; n = 17 sh-Ngb neurons in total analyzed from 4 mice) lentivirus (n = 34 neurons in total from 8 mice *p < 0.05). Statistical significance
was analyzed by one-way ANOVA followed by Tukey’s post hoc analysis. (D) Graph representing the area under the curve calculated from Panel C (*p < 0.05). The
graph shows the mean ± SEM. Statistical significance was analyzed by t test. (E–G) Dendritic bifurcations (E) and higher-order dendritic branches (F) are less
abundant in neurons infected with sh-Ngb, while no differences are observed for primary dendritic branches (**p < 0.01). The graphs show the mean ± SEM.
Statistical significance was analyzed by one-way ANOVA followed by Tukey’s post hoc analysis (C) and t test (D–G).
TABLE 1 | Demographics and neuropsychological tests.
Stable Converters
Visit 1 Visit 2 Visit 1 Visit 2
Gender 7F/7M 5F/2M
Age (mean ± SD) 75.07 ± 0.26 74.85 ± 4.29
MMSE 28.57 28.43 26.85 26.43
FAQ 0.07 0.22 1.43 6.33
FLUIsem 18.72 19.36 14.43 12.43
CDR 0 0 0 0.5
Demographics and scores obtained during the neuropsychological evaluation for
the different tests and for the two groups analyzed (Stable and Converters). The
neuropsychological evaluation in Visit 2 occurred 5 years after Visit 1.
with no effect on primary branches (Figure 5G). On the
other hand, Ngb downregulation did not result in more
amyloid plaques (Supplementary Figure S5C) or neuronal loss
(Supplementary Figure S6) near the injected area, suggesting
that the upregulation of Ngb that constitutively occurs in the
hAPP NL/F mice is interfering with Aβ toxicity. According to the
observation that Ngb increases with age in the hAPP NL/F but
not wild type mice, reduction of Ngb in the brain of old wild type
mice had no consequences on dendritic tree architecture.
Plasma Levels of NGB May Predict
Conversion to Mild Cognitive Impairment
Our data supports a role of NGB in offering protection to
neurons against Aβ-induced toxicity. Thus, people with lower
levels of NGB in the brain may be at higher risk of cognitive
impairment, especially in the elderly as a consequence of the
higher levels of toxic Aβ species generated (Dewachter et al., 2000;
Placanica et al., 2009; Guix et al., 2012; Janssen et al., 2016). We
tested this possibility by analyzing blood NGB levels. We took
this approach based on the previous demonstration that NGB
levels were shown to peak up 72 h after an episode of acute
ischemic stroke (Xue et al., 2017). With the aim of determining
if lower plasma NGB levels are associated with a higher risk of
developing dementia, we carried out a pilot longitudinal study to
determine the NGB levels from plasma of healthy donors drawn
the first visit (V1) and 5 years later (V5), when some of them
had developed different degrees of cognitive impairment (see
Table 1). Then we calculated the difference in plasma NGB levels
between V5 and V1 and compared the degree of change between
donors who stayed cognitively stable at V5 (Stables; n = 14) and
donors who showed a mild cognitive impairment (MCI) at V5
(converters; n = 7) (Table 2). Interestingly, the highest drops in
plasma NGB levels were detected in the group of the converters
(Figures 6A,B). In average, the group of converters showed a
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TABLE 2 | Determination of neuroglobin (Ngb) levels in the plasma.
Sample ID Visit 1 (V1) Visit 5 (V5) Visit 1 (V1) Visit 5 (V5) V5-V1
Diagnose Diagnose Ngb [ng/mg Ngb [ng/mg Ngb [ng/mg
protein] protein] protein]
0223 non-MCI non-MCI 0.098 0.084 −0.014
0338 non-MCI non-MCI 0.068 0.046 −0.022
0418 non-MCI non-MCI 0.121 0.125 0.004
0688 non-MCI non-MCI 0.076 0.132 0.056
0894 non-MCI non-MCI 0.121 0.088 −0.033
0945 non-MCI non-MCI 0.050 0.107 0.057
0012 non-MCI non-MCI 0.079 0.039 −0.040
0111 non-MCI non-MCI 0.051 0.060 0.009
0282 non-MCI non-MCI 0.061 0.075 0.014
0562 non-MCI non-MCI 0.060 0.041 −0.020
0742 non-MCI non-MCI 0.074 0.089 0.015
0762 non-MCI non-MCI 0.087 0.112 0.025
0888 non-MCI non-MCI 0.087 0.071 −0.015
1102 non-MCI non-MCI 0.045 0.042 −0.003
0090 non-MCI MCI 0.121 0.064 −0.057
0270 non-MCI MCI 0.154 0.070 −0.084
0308 non-MCI MCI 0.084 0.081 −0.003
0611 non-MCI MCI 0.165 0.074 −0.091
0770 non-MCI MCI 0.035 0.063 0.029
0912 non-MCI MCI 0.039 0.076 0.037
1177 non-MCI MCI 0.047 0.054 0.008
The table shows the Ngb levels (normalized by total protein) from plasma of healthy
donors drawn the first visit (V1) and 5 years later (V5), when some of them had
developed different degrees of cognitive impairment (MCI) (see Table 1). The
difference in plasma Ngb levels between V5 and V1 (V5-V1) was calculated.
tendency to decrease plasma NGB levels between V1 and V5,
but it did not reach statistical significance (Figure 6C). On the
other hand, when we compared the plasma NGB levels with the
score obtained in different neuropsychological tests we found
that subjects with a lower FLUIsem, a semantic fluidity test used
to diagnose dementia in which a score below 15 is associated
to mild dementia (Pena-Casanova et al., 2009), presented lower
NGB levels (Table 1 and Figure 6D).
DISCUSSION
Several works have demonstrated the protective capacity of
Ngb in different brain toxicity contexts, including AD (Khan
et al., 2007; Li et al., 2008b, 2010, 2016; Chen et al.,
2012). However, no previous work has shown that this
route of protection is constitutively activated in vivo, both
in the mouse and human brain, in parallel to age and Aβ
increase, and that this increase is required to prevent the
appearance of one of the earliest signs of disease: neuronal
architectural deficiencies. Herein, in the demonstration that
Ngb upregulation is a physiological protective response, lies the
originality of our work.
A number of observations support the above conclusion: (1)
the levels of Ngb increase with age and in parallel to the increase
in brain Aβ in the hAPP NL/F mice, not in wild type; (2) Ngb is
activated by Aβ, in an oxidative stress mediated manner, which
is consistent with the role of Ngb as an anti-oxidant (in fact,
we found that the hAPP NL/F/G knock-in mice, which present
earlier Aβ deposition in comparison to the hAPP NL/F mice,
show a statistically significant increase of Ngb as early as at 11–
13 months of age (Supplementary Figure S7), (3) its increase in
wild type neurons prevents the cytoarchitectural defects induced
by Aβ, (4) its downregulation in vivo, in the hAPP NL/F mice
leads to the appearance of dendritic tree simplification. Although
it would seem logical to attempt to confirm the relevance of
Ngb in the prevention of AD phenotype by crossing the hAPP
NL/F mice with Ngb KO mice (Hundahl et al., 2012), these
mice do not present abnormalities in anatomy, neuronal loss,
body composition or behavior, implying that Ngb physiological
(protective) roles can be efficiently compensated when missing
constitutively by any of the multiple survival mechanisms present
in neurons (Hundahl et al., 2011, 2012). In support to this
hypothesis, it was unexpectedly found that Ngb-null mice showed
a reduced infarct size after inducing an experimental stroke
(Raida et al., 2012). Thus, the acute reduction of Ngb via shRNA
that we have done in this work gives a valid approximation
to the possible function of this protein in conditions of supra-
physiological stressors, such as the high levels of toxic forms of
Aβ. However, crossing hAPP NL-F mice with inducible KO Ngb
mice could certainly strengthen (or weaken) our interpretation.
Given that the simplification of the dendritic tree is one
of the earliest events of Aβ toxicity (Yamada et al., 1988;
Flood, 1991; Hanks and Flood, 1991; Tsai et al., 2004;
Grutzendler et al., 2007), we find reasonable to propose that
the increase in Ngb is in the first line of defense against
the harmful effects of Aβ. Although the increase in Ngb
may also counteract the toxicity derived from the high levels
of PHF1 observed in old hAPP NL/F mice, we cannot
exclude that the increase in PHF1 in the old hAPP NL-F
is itself a sign of resistance to neuronal death rather than
of degeneration (Li et al., 2007; Yang and Wang, 2018).
From mechanistic data provided in previous studies on the
anti-apoptotic role of Ngb, we presume the protection of
architectural integrity of dendrites by Ngb in a high Aβ
context is indirect, through the inhibition of mitochondrial
damage-induced ROS/NO production (Raychaudhuri et al.,
2010; Tiso et al., 2011) which are known to affect the stability
of microtubules (Landino et al., 2004; Fukui et al., 2011).
On the other hand, the protection against the occurrence of
architectural deficiencies by Ngb is important so that no major
damage by Aβ occurs. As a matter of fact, previous works
have shown that overexpression of Ngb prevents Aβ-induced
cell death (Khan et al., 2007; Li et al., 2008b, 2016) and
attenuates memory impairment and amyloid plaque formation
(Li et al., 2016), all of them late events in the course of AD.
However, the observation of a drop in NGB plasma levels
in individuals who have progressed from cognitive normal
to MCI -which we assume reflects a drop in brain levels-,
together with the mice data would imply that NGB is a
defensive mechanism during the early phases of Alzheimer’s
disease. In support of this possibility are also the results
showing that a polymorphism in Ngb that decreases the
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FIGURE 6 | Cognitively altered patients show a decrease in Ngb plasma levels. (A) Representation of the differences in the levels of plasma neuroglobin, normalized
by total protein, calculated from the blood of individuals (n = 14) extracted in the first visit (V1) and the fifth visit, 5 years later (V5), and who did not show a cognitive
decline between V5 and V1 determined by several neurological and neuropsychological tests (Stable). The plasma Ngb levels obtained at V1 was set at 0 for
comparative purposes. (B) Same representation as in A, but for individuals with signs of mild cognitive impairment (MCI) at V5 versus V1 (Converters). (C) Bar plot
illustrating the differences in Ngb levels (normalized by total plasma proteins) between V5 versus V1, for Stable (n = 14) and Converters (n = 7) Individuals. Negative
values indicate a decrease in absolute Ngb levels between V1 and V5. (D) Correlation between the amount of Ngb levels change (V5 versus V1) and the score
obtained by the neuropsychological semantic fluency test FLUIsem. Subjects who score less than 15 in this test are considered to have mild dementia. Negative
values in the X axis indicates a decrease in absolute Ngb levels between V1 and V5.
expression of the protein increases the risk of developing AD
(Szymanski et al., 2010).
The acceptance of the scenario described above would
be compatible with the idea that elevating the NGB levels
during the early clinical phases of the disease may prevent
the progression of AD symptoms. That this is a reasonable
therapeutic approach comes from the recent demonstration
that systemic administration of a recombinant NGB, with
higher oxygen binding affinity and higher NO reduction
capacity, is effective to prevent carbon monoxide poisoning
(Azarov et al., 2016).
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed
and approved by Ethics Committee of the Carlos III
Institute of Health. The patients/participants provided
their written informed consent to participate in this study.
The animal study was reviewed and approved by CBMSO’s
Ethical Committee.
AUTHOR CONTRIBUTIONS
CD designed the overall approach, coordinated the study, and
drafted the manuscript. SV, FG, and CD prepared the manuscript.
SV did most of the biological studies and statistical analysis of the
data. FG contributed to the design of the different experiments
and executed a number of them. IP-P prepared neuronal primary
Frontiers in Neuroscience | www.frontiersin.org 14 December 2020 | Volume 14 | Article 562581
fnins-14-562581 November 28, 2020 Time: 12:47 # 15
de Vidania et al. NGB Prevents Initiation of AD
cultures and handled the experimental animal model. AF-G
revised the manuscript and provided intellectual inputs. TS and
TCS provided the knock-in mice. JD did the electrophysiological
studies. MS and LC-G determined the Aß levels. MC and MM
provided the human plasma samples. MM provided critical
analysis of the experiments and the results. All authors read and
approved the final manuscript.
FUNDING
This work was partially supported by the Stichting Alzheimer
Onderzoek (SAO; S16013) and the FWO (research project
G0B2519N) to LC-G, SAF2016-76722 (AEI/FEDER, UE) to
CD, Marie Skłodowska-Curie Actions – Individual Fellowships
(T2DM and AD, EU 708152) to FG and EU JPND “EpiAD” Grant
to AF-G and CD, SAF2016-78603-R to MM and MC.
ACKNOWLEDGMENTS
We thank César Venero (Faculty of Psychology, Department
of Psychobiology, UNED, Madrid, Spain) for help with the
behavior assays and the Electron Microscopy Service of the
Centro de Biología Molecular Severo Ochoa (http://www.cbm.
uam.es/joomla-rl/index.php/es/investigacion/servicios-cientifico
s/microscopia-electronica) for the analysis of Aβ oligomers. We
also thank to the Vallecas Project Team for the phenotyping of
human volunteers.
SUPPLEMENTARY MATERIAL




Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas,
N. D., et al. (2008). Frequent amyloid deposition without significant cognitive
impairment among the elderly. Arch. Neurol. 65, 1509–1517. doi: 10.1001/
archneur.65.11.1509
Amri, F., Ghouili, I., Amri, M., Carrier, A., and Masmoudi-Kouki, O.
(2017). Neuroglobin protects astroglial cells from hydrogen peroxide-induced
oxidative stress and apoptotic cell death. J. Neurochem. 140, 151–169. doi:
10.1111/jnc.13876
Arboleda-Velasquez, J. F., Lopera, F., O’Hare, M., Delgado-Tirado, S., Marino, C.,
Chmielewska, N., et al. (2019). Resistance to autosomal dominant Alzheimer’s
disease in an APOE3 christchurch homozygote: a case report. Nat. Med. 25,
1680–1683. doi: 10.1038/s41591-019-0611-3
Azarov, I., Wang, L., Rose, J. J., Xu, Q., Huang, X. N., Belanger, A., et al.
(2016). Five-coordinate H64Q neuroglobin as a ligand-trap antidote for carbon
monoxide poisoning. Sci. Transl. Med. 8:368ra173. doi: 10.1126/scitranslmed.
aah6571
Bateman, D. A., McLaurin, J., and Chakrabartty, A. (2007). Requirement of
aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface
binding. BMC Neurosci. 8:29. doi: 10.1186/1471-2202-8-29
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T.,
Shah, R. C., et al. (2006). Neuropathology of older persons without cognitive
impairment from two community-based studies. Neurology 66, 1837–1844.
doi: 10.1212/01.wnl.0000219668.47116.e6
Burmester, T., Weich, B., Reinhardt, S., and Hankeln, T. (2000). A vertebrate globin
expressed in the brain. Nature 407, 520–523. doi: 10.1038/35035093
Bussini, S., Meda, L., Scarpini, E., Clementi, E., Conti, G., Tiriticco, M., et al. (2005).
Heparan sulfate proteoglycan induces the production of NO and TNF-alpha by
murine microglia. Immun. Ageing 2:11. doi: 10.1186/1742-4933-2-11
Butterfield, D. A., and Boyd-Kimball, D. (2019). Redox proteomics and amyloid
beta-peptide: insights into Alzheimer disease. J. Neurochem. 151, 459–487. doi:
10.1111/jnc.14589
Chen, L. M., Xiong, Y. S., Kong, F. L., Qu, M., Wang, Q., Chen, X. Q., et al.
(2012). Neuroglobin attenuates Alzheimer-like tau hyperphosphorylation by
activating Akt signaling. J. Neurochem. 120, 157–164. doi: 10.1111/j.1471-4159.
2011.07275.x
Deng, L., Pushpitha, K., Joseph, C., Gupta, V., Rajput, R., Chitranshi, N.,
et al. (2019). Amyloid beta induces early changes in the ribosomal
machinery, cytoskeletal organization and oxidative phosphorylation in retinal
photoreceptor cells. Front. Mol. Neurosci. 12:24. doi: 10.3389/fnmol.2019.00024
Dewachter, I., Van Dorpe, J., Smeijers, L., Gilis, M., Kuiperi, C., Laenen, I., et al.
(2000). Aging increased amyloid peptide and caused amyloid plaques in brain
of old APP/V717I transgenic mice by a different mechanism than mutant
presenilin1. J. Neurosci. 20, 6452–6458. doi: 10.1523/jneurosci.20-17-06452.
2000
Dinamarca, M. C., Rios, J. A., and Inestrosa, N. C. (2012). Postsynaptic receptors
for amyloid-beta oligomers as mediators of neuronal damage in Alzheimer’s
disease. Front. Physiol. 3:464. doi: 10.3389/fphys.2012.00464
El-Agnaf, O. M., Mahil, D. S., Patel, B. P., and Austen, B. M. (2000).
Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer’s
disease. Biochem. Biophys. Res. Commun. 273, 1003–1007. doi: 10.1006/bbrc.
2000.3051
Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz,
J. B., et al. (2015). Identification of preclinical Alzheimer’s disease by a profile of
pathogenic proteins in neurally derived blood exosomes: a case-control study.
Alzheimers Dement. 11, 600.e1–607.e1. doi: 10.1016/j.jalz.2014.06.008
Flood, D. G. (1991). Region-specific stability of dendritic extent in normal human
aging and regression in Alzheimer’s disease. II. Subiculum. Brain Res. 540,
83–95. doi: 10.1016/0006-8993(91)90494-g
Fukui, K., Takatsu, H., Koike, T., and Urano, S. (2011). Hydrogen peroxide induces
neurite degeneration: prevention by tocotrienols. Free Radic. Res. 45, 681–691.
doi: 10.3109/10715762.2011.567984
Giordano, C. R., Terlecky, L. J., Bollig-Fischer, A., Walton, P. A., and Terlecky, S. R.
(2014). Amyloid-beta neuroprotection mediated by a targeted antioxidant. Sci.
Rep. 4:4983. doi: 10.1038/srep04983
Golovyashkina, N., Penazzi, L., Ballatore, C., Smith, A. B. III, Bakota, L., and
Brandt, R. (2015). Region-specific dendritic simplification induced by Abeta,
mediated by tau via dysregulation of microtubule dynamics: a mechanistic
distinct event from other neurodegenerative processes. Mol. Neurodegener.
10:60. doi: 10.1186/s13024-015-0049-0
Grutzendler, J., Helmin, K., Tsai, J., and Gan, W. B. (2007). Various
dendritic abnormalities are associated with fibrillar amyloid deposits in
Alzheimer’s disease. Ann. N. Y. Acad. Sci. 1097, 30–39. doi: 10.1196/annals.13
79.003
Guix, F. X., Wahle, T., Vennekens, K., Snellinx, A., Chavez-Gutierrez, L., Ill-Raga,
G., et al. (2012). Modification of gamma-secretase by nitrosative stress links
neuronal ageing to sporadic Alzheimer’s disease. EMBO Mol. Med. 4, 660–673.
doi: 10.1002/emmm.201200243
Hanks, S. D., and Flood, D. G. (1991). Region-specific stability of dendritic extent
in normal human aging and regression in Alzheimer’s disease. I. CA1 of
hippocampus. Brain Res. 540, 63–82. doi: 10.1016/0006-8993(91)90493-f
Haroutunian, V., Purohit, D. P., Perl, D. P., Marin, D., Khan, K., Lantz, M.,
et al. (1999). Neurofibrillary tangles in nondemented elderly subjects and mild
Alzheimer disease. Arch. Neurol. 56, 713–718. doi: 10.1001/archneur.56.6.713
Hundahl, C. A., Fahrenkrug, J., Hay-Schmidt, A., Georg, B., Faltoft, B., and
Hannibal, J. (2012). Circadian behaviour in neuroglobin deficient mice. PLoS
One 7:e34462. doi: 10.1371/journal.pone.0034462
Hundahl, C. A., Luuk, H., Ilmjarv, S., Falktoft, B., Raida, Z., Vikesaa, J., et al. (2011).
Neuroglobin-deficiency exacerbates Hif1A and c-FOS response, but does not
affect neuronal survival during severe hypoxia in vivo. PLoS One 6:e28160.
doi: 10.1371/journal.pone.0028160
Frontiers in Neuroscience | www.frontiersin.org 15 December 2020 | Volume 14 | Article 562581
fnins-14-562581 November 28, 2020 Time: 12:47 # 16
de Vidania et al. NGB Prevents Initiation of AD
Janssen, L., Keppens, C., De Deyn, P. P., and Van Dam, D. (2016). Late age increase
in soluble amyloid-beta levels in the APP23 mouse model despite steady-
state levels of amyloid-beta-producing proteins. Biochim. Biophys. Acta 1862,
105–112. doi: 10.1016/j.bbadis.2015.10.027
Kenny, A., McArdle, H., Calero, M., Rabano, A., Madden, S., Spain, E., et al.
(2019). Elevated plasma microRNA-206 levels predict cognitive decline and
progression to dementia from mild cognitive impairment. Biomolecules 9:734.
doi: 10.3390/biom9110734
Khan, A. A., Mao, X. O., Banwait, S., Jin, K., and Greenberg, D. A. (2007).
Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic
Alzheimer phenotype in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 19114–19119.
doi: 10.1073/pnas.0706167104
Landino, L. M., Moynihan, K. L., Todd, J. V., and Kennett, K. L. (2004). Modulation
of the redox state of tubulin by the glutathione/glutaredoxin reductase system.
Biochem. Biophys. Res. Commun. 314, 555–560. doi: 10.1016/j.bbrc.2003.
12.126
Li, H. L., Wang, H. H., Liu, S. J., Deng, Y. Q., Zhang, Y. J., Tian, Q., et al. (2007).
Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a
mechanism involved in Alzheimer’s neurodegeneration. Proc. Natl. Acad. Sci.
U.S.A. 104, 3591–3596. doi: 10.1073/pnas.0609303104
Li, R. C., Guo, S. Z., Lee, S. K., and Gozal, D. (2010). Neuroglobin protects neurons
against oxidative stress in global ischemia. J. Cereb. Blood Flow Metab. 30,
1874–1882. doi: 10.1038/jcbfm.2010.90
Li, R. C., Morris, M. W., Lee, S. K., Pouranfar, F., Wang, Y., and Gozal, D.
(2008a). Neuroglobin protects PC12 cells against oxidative stress. Brain Res.
1190, 159–166. doi: 10.1016/j.brainres.2007.11.022
Li, R. C., Pouranfar, F., Lee, S. K., Morris, M. W., Wang, Y., and Gozal, D. (2008b).
Neuroglobin protects PC12 cells against beta-amyloid-induced cell injury.
Neurobiol. Aging 29, 1815–1822. doi: 10.1016/j.neurobiolaging.2007.05.001
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., and Selkoe, D.
(2009). Soluble oligomers of amyloid Beta protein facilitate hippocampal long-
term depression by disrupting neuronal glutamate uptake. Neuron 62, 788–801.
doi: 10.1016/j.neuron.2009.05.012
Li, Y., Dai, Y. B., Sun, J. Y., Xiang, Y., Yang, J., Dai, S. Y., et al. (2016). Neuroglobin
attenuates beta amyloid-induced apoptosis through inhibiting caspases activity
by activating PI3K/Akt signaling pathway. J. Mol. Neurosci. 58, 28–38. doi:
10.1007/s12031-015-0645-z
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods 25, 402–408. doi: 10.1006/meth.2001.1262
Lukiw, W. J. (2004). Gene expression profiling in fetal, aged, and Alzheimer
hippocampus: a continuum of stress-related signaling. Neurochem. Res. 29,
1287–1297. doi: 10.1023/b:nere.0000023615.89699.63
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., et al. (2004).
ABAD directly links Abeta to mitochondrial toxicity in Alzheimer’s disease.
Science 304, 448–452. doi: 10.1126/science.1091230
Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P.,
et al. (2010). Mitochondria-targeted antioxidants protect against amyloid-
beta toxicity in Alzheimer’s disease neurons. J. Alzheimers Dis. 20(Suppl. 2),
S609–S631. doi: 10.3233/JAD-2010-100564
Masuda, A., Kobayashi, Y., Kogo, N., Saito, T., Saido, T. C., and Itohara, S. (2016).
Cognitive deficits in single App knock-in mouse models. Neurobiol. Learn.
Mem. 135, 73–82. doi: 10.1016/j.nlm.2016.07.001
Olazarán, J., Valentí, M., Frades, B., Zea-Sevilla, M. A., Ávila-Villanueva, M.,
Fernández-Blázquez, M. A., et al. (2015). The vallecas project: a cohort to
identify early markers and mechanisms of Alzheimer’s disease. Front. Aging
Neurosci. 7:181. doi: 10.3389/fnagi.2015.00181
Ono, K., Hamaguchi, T., Naiki, H., and Yamada, M. (2006). Anti-amyloidogenic
effects of antioxidants: implications for the prevention and therapeutics of
Alzheimer’s disease. Biochim. Biophys. Acta 1762, 575–586. doi: 10.1016/j.
bbadis.2006.03.002
Pena-Casanova, J., Quinones-Ubeda, S., Gramunt-Fombuena, N., Quintana-
Aparicio, M., Aguilar, M., Badenes, D., et al. (2009). Spanish multicenter
normative studies (NEURONORMA Project): norms for verbal fluency tests.
Arch. Clin. Neuropsychol. 24, 395–411. doi: 10.1093/arclin/acp042
Perez-Gonzalez, M., Mendioroz, M., Badesso, S., Sucunza, D., Roldan, M.,
Espelosín, M., et al. (2020). PLA2 G4E, a candidate gene for resilience in
Alzheimer’s disease and a new target for dementia treatment. Prog. Neurobiol.
191:101818. doi: 10.1016/j.pneurobio.2020.101818
Placanica, L., Zhu, L., and Li, Y. M. (2009). Gender- and age-dependent gamma-
secretase activity in mouse brain and its implication in sporadic Alzheimer
disease. PLoS One 4:e5088. doi: 10.1371/journal.pone.0005088
Price, J. L., and Morris, J. C. (1999). Tangles and plaques in nondemented aging
and "preclinical" Alzheimer’s disease. Ann. Neurol. 45, 358–368. doi: 10.1002/
1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
Raida, Z., Hundahl, C. A., Kelsen, J., Nyengaard, J. R., and Hay-Schmidt, A. (2012).
Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo.
Exp. Transl. Stroke Med. 4:15. doi: 10.1186/2040-7378-4-15
Rajasekhar, K., Samanta, S., Bagoband, V., Murugan, N. A., and Govindaraju, T.
(2020). Antioxidant berberine-derivative inhibits multifaceted amyloid toxicity.
iScience 23:101005. doi: 10.1016/j.isci.2020.101005
Raychaudhuri, S., Skommer, J., Henty, K., Birch, N., and Brittain, T. (2010).
Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic
pathway of cell death. Apoptosis 15, 401–411. doi: 10.1007/s10495-009-0
436-5
Rodriguez-Vieitez, E., Saint-Aubert, L., Carter, S. F., Almkvist, O., Farid, K., Scholl,
M., et al. (2016). Diverging longitudinal changes in astrocytosis and amyloid
PET in autosomal dominant Alzheimer’s disease. Brain 139(Pt 3), 922–936.
doi: 10.1093/brain/awv404
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., et al. (2014).
Single App knock-in mouse models of Alzheimer’s disease. Nat. Neurosci. 17,
661–663. doi: 10.1038/nn.3697
Smith, D. G., Cappai, R., and Barnham, K. J. (2007). The redox chemistry of
the Alzheimer’s disease amyloid beta peptide. Biochim. Biophys. Acta 1768,
1976–1990. doi: 10.1016/j.bbamem.2007.02.002
Streltsov, V. A., Titmuss, S. J., Epa, V. C., Barnham, K. J., Masters, C. L., and
Varghese, J. N. (2008). The structure of the amyloid-beta peptide high-affinity
copper II binding site in Alzheimer disease. Biophys. J. 95, 3447–3456. doi:
10.1529/biophysj.108.134429
Szymanski, M., Wang, R., Fallin, M. D., Bassett, S. S., and Avramopoulos,
D. (2010). Neuroglobin and Alzheimer’s dementia: genetic association and
gene expression changes. Neurobiol. Aging 31, 1835–1842. doi: 10.1016/j.
neurobiolaging.2008.10.003
Tiso, M., Tejero, J., Basu, S., Azarov, I., Wang, X., Simplaceanu, V., et al. (2011).
Human neuroglobin functions as a redox-regulated nitrite reductase. J. Biol.
Chem. 286, 18277–18289. doi: 10.1074/jbc.M110.159541
Troncoso, J. C., Cataldo, A. M., Nixon, R. A., Barnett, J. L., Lee, M. K., Checler, F.,
et al. (1998). Neuropathology of preclinical and clinical late-onset Alzheimer’s
disease. Ann. Neurol. 43, 673–676. doi: 10.1002/ana.410430519
Troncoso, J. C., Martin, L. J., Dal Forno, G., and Kawas, C. H. (1996).
Neuropathology in controls and demented subjects from the baltimore
longitudinal study of aging. Neurobiol. Aging 17, 365–371. doi: 10.1016/0197-
4580(96)00028-0
Tsai, J., Grutzendler, J., Duff, K., and Gan, W. B. (2004). Fibrillar amyloid
deposition leads to local synaptic abnormalities and breakage of neuronal
branches. Nat. Neurosci. 7, 1181–1183. doi: 10.1038/nn1335
Uchida, Y., Nakano, S., Gomi, F., and Takahashi, H. (2011). Up-regulation of
calsyntenin-3 by beta-amyloid increases vulnerability of cortical neurons. FEBS
Lett. 585, 651–656. doi: 10.1016/j.febslet.2011.01.025
Ungureanu, A. A., Benilova, I., Krylychkina, O., Braeken, D., De Strooper, B.,
Van Haesendonck, C., et al. (2016). Amyloid beta oligomers induce neuronal
elasticity changes in age-dependent manner: a force spectroscopy study on
living hippocampal neurons. Sci. Rep. 6:25841. doi: 10.1038/srep25841
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S.,
et al. (2002). Naturally secreted oligomers of amyloid beta protein potently
inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539. doi:
10.1038/416535a
Watanabe, S., Takahashi, N., Uchida, H., and Wakasugi, K. (2012). Human
neuroglobin functions as an oxidative stress-responsive sensor for
neuroprotection. J. Biol. Chem. 287, 30128–30138. doi: 10.1074/jbc.M112.
373381
Wu, H. Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z.,
et al. (2010). Amyloid beta induces the morphological neurodegenerative
triad of spine loss, dendritic simplification, and neuritic dystrophies through
Frontiers in Neuroscience | www.frontiersin.org 16 December 2020 | Volume 14 | Article 562581
fnins-14-562581 November 28, 2020 Time: 12:47 # 17
de Vidania et al. NGB Prevents Initiation of AD
calcineurin activation. J. Neurosci. 30, 2636–2649. doi: 10.1523/JNEUROSCI.
4456-09.2010
Xue, L., Chen, H., Lu, K., Huang, J., Duan, H., and Zhao, Y. (2017). Clinical
significance of changes in serum neuroglobin and HIF-1alpha concentrations
during the early-phase of acute ischemic stroke. J. Neurol. Sci. 375, 52–57.
doi: 10.1016/j.jns.2017.01.039
Yamada, M., Wada, Y., Tsukagoshi, H., Otomo, E., and Hayakawa, M. (1988).
A quantitative Golgi study of basal dendrites of hippocampal CA1 pyramidal
cells in senile dementia of Alzheimer type. J. Neurol. Neurosurg. Psychiatry 51,
1088–1090. doi: 10.1136/jnnp.51.8.1088
Yan, Y., and Wang, C. (2006). Abeta42 is more rigid than Abeta40 at the C
terminus: implications for Abeta aggregation and toxicity. J. Mol. Biol. 364,
853–862. doi: 10.1016/j.jmb.2006.09.046
Yan, Y., and Wang, C. (2008). Protection mechanisms against Abeta42 aggregation.
Curr. Alzheimer Res. 5, 548–554. doi: 10.2174/156720508786898460
Yang, Y., and Wang, J. Z. (2018). Nature of Tau-associated neurodegeneration and
the molecular mechanisms. J. Alzheimers Dis. 62, 1305–1317. doi: 10.3233/JAD-
170788
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 de Vidania, Palomares-Perez, Frank-García, Saito, Saido, Draffin,
Szaruga, Chávez-Gutierrez, Calero, Medina, Guix and Dotti. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 17 December 2020 | Volume 14 | Article 562581
